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Dallas, TexasObjectives This study sought to compare and contrast use and radiation exposure using radial versus
femoral access during cardiac catheterization of patients who had previously undergone coronary
artery bypass graft (CABG) surgery.
Background Limited information is available on the relative merits of radial compared with femoral
access for cardiac catheterization in patients who had previously undergone CABG surgery.
Methods Consecutive patients (N ¼ 128) having previously undergone CABG surgery and referred for
cardiac catheterization were randomized to radial or femoral access. The primary study endpoint was
contrast volume. Secondary endpoints included ﬂuoroscopy time, procedure time, patient and
operator radiation exposure, vascular complications, and major adverse cardiac events. Analyses were
by intention-to-treat.
Results Compared with femoral access, diagnostic coronary angiography via radial access was
associated with a higher mean contrast volume (142  39 ml vs. 171  72 ml, p < 0.01), longer
procedure time (21.9  6.8 min vs. 34.2  14.7 min, p < 0.01), greater patient air kerma (kinetic energy
released per unit mass) radiation exposure (1.08  0.54 Gy vs. 1.29  0.67 Gy, p ¼ 0.06), and higher
operator radiation dose (ﬁrst operator: 1.3  1.0 mrem vs. 2.6  1.7 mrem, p < 0.01; second operator
0.8  1.1 mrem vs. 1.8  2.1 mrem, p ¼ 0.01). Fewer patients underwent ad hoc percutaneous
coronary intervention (PCI) in the radial group (37.5% vs. 46.9%, p ¼ 0.28) and radial PCI procedures
were less complex. The incidences of the primary and secondary endpoints was similar with femoral
and radial access among PCI patients. Access crossover was higher in the radial group (17.2% vs. 0.0%,
p < 0.01) and vascular access site complications were similar in both groups (3.1%).
Conclusions In patients who had previously undergone CABG surgery, transradial diagnostic coronary
angiography was associated with greater contrast use, longer procedure time, and greater access
crossover and operator radiation exposure compared with transfemoral angiography. (RADIAL Versus
Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention [RADIAL-CABG] Trial;
NCT01446263). (J Am Coll Cardiol Intv 2013;6:1138–44) ª 2013 by the American College of
Cardiology FoundationFrom the VA North Texas Healthcare System and University of Texas Southwestern Medical Center, Dallas, Texas. Dr. Michael has
received a cardiovascular training grant from the National Institutes of Health, Award Number T32HL007360. Dr. Banerjee is on the
Speakers’ Bureau of St. Jude Medical, Medtronic Corp., and Johnson & Johnson; is a consultant for Medtronic and Covidien; and has
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CABG = coronary artery
bypass graft
MACE = major adverse
cardiac event(s)
PCI = percutaneous coronary
intervention
TF = transfemoral
TR = transradial
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1139Several studies have demonstrated that compared with
transfemoral (TF) access cardiac catheterization and percu-
taneous coronary intervention (PCI), using transradial
(TR) access is associated with lower rates of vascular and
bleeding complications (1–4), reduced mortality (5–7),
earlier ambulation (8), and improved patient satisfaction (9).
However, there are limited data on the role of TR cathe-
terization in patients who previously underwent coronary
artery bypass graft (CABG) surgery (10–13), who were
often excluded or underrepresented in TR access studies
(4,7,14,15). Although observational studies have suggested
that TR PCI in patients who had previously undergone
CABG surgery is feasible and safe (10–13), it is technically
more challenging than procedures performed via TF access.
We conducted the RADIAL-CABG (RADIAL Versus
Femoral Access for Coronary Artery Bypass Graft Angi-
ography and Intervention) trial to compare contrast volume,
radiation exposure, and procedural clinical outcomes of
diagnostic coronary angiography and PCI among patients
who had previously undergone CABG surgery and were
randomized to TR versus TF access.
Methods
Study design and patient population. The RADIAL-CABG
trial was a single-center, prospective, randomized, controlled
clinical trial designed to compare procedural variables and
outcomes of TR versus TF catheterization in patients who had
previously undergone CABG surgery and were referred for
clinically indicated coronary angiography and PCI. Between
October 2011 and March 2013, all patients who
had previously undergone CABG surgery and were referred
for diagnostic or interventional cardiac catheterization at our
institution were screened for participation. Patients presenting
with ST-segment elevation acute myocardial infarction,
abnormal Allen test results, known difﬁculty obtaining
vascular access via either the femoral or radial artery, or age
>90 years were excluded. The study was approved by the
Dallas VA Medical Center institutional review board, and all
patients provided written informed consent before cardiac
catheterization. Patients were randomized to TR or TF access
in a 1:1 ratio using opaque, numbered, sealed envelopes
containing randomization assignment based on a computer-
generated random sequence.
Procedure description. TF catheterization was performed
via the right or left common femoral artery, as clinically
indicated. Hemostasis was achieved using manual com-
pression or a vascular closure device, at the operator’sreceived a research grant from Boston Scientiﬁc and an institutional research grant
from Gilead; his spouse has ownership of Mdcareglobal; and has intellectual property
with HygeiaTel. Dr. Brilakis has received consulting fees/speaker honoraria from St.
Jude Medical, Terumo, Janssen, sanoﬁ-aventis, Asahi, Abbott Vascular and Bridge-
point Medical/Boston Scientiﬁc; and research support from Guerbet; and his spouse isdiscretion. TR catheterization was performed via the left
radial artery in all patients to facilitate cannulation of the left
internal mammary artery graft. In most cases, the operator
was standing on the right side of the patient. Intravenous
heparin (70 U/kg) and intra-arterial nitroglycerin (200 mg)
were administered via the radial sheath to prevent arterial
spasm and thrombosis. At the end of each TR procedure,
a TR band (Terumo, Somerset, New Jersey) was applied for
15 to 60 min to achieve patent hemostasis.
Operators. Each procedure was performed by 2 operators.
The ﬁrst operator was usually a cardiology trainee and the
second operator an interventional cardiologist with TR
expertise (>1,000 procedures performed). If the ﬁrst oper-
ator failed to obtain arterial access after 2 or 3 attempts, the
second operator obtained arterial access. Similarly, if the
ﬁrst operator failed to engage the target coronary arteries
or bypass grafts within 2 to 3 min, the second operator
performed the native coronary artery and bypass graft
cannulation.
Endpoints. The primary study endpoint was the volume of
radiographic contrast administered during cardiac catheteri-
zation. Secondary endpoints
included ﬂuoroscopy time, total
procedure time (deﬁned as the
interval between administration
of local anesthesia for obtaining
vascular access and removal of the
last catheter), radiation exposure
of the patient and operators,
vascular access crossover, vascular
access complications, and peri-
procedural major adverse cardiac
events (MACE). All endpoints
were assessed separately for diagnostic angiography and for
PCI (i.e., measurements for diagnostic catheterization ended
with completion of diagnostic angiography and measure-
ments for PCI began on PCI initiation and ended on PCI
completion).MACEwere deﬁned as all-cause death, Q-wave
myocardial infarction, recurrent angina requiring urgent
repeat target vessel revascularization with PCI or coronary
bypass surgery, and stroke occurring before hospital discharge.
Vascular complications included hematoma, aneurysm,
pseudoaneurysm, arteriovenous ﬁstula formation, retroperi-
toneal hematoma, dissection, and limb ischemia. Major
bleeding was deﬁned as a hemoglobin decrease of at least 3 g/
dl or administration of a blood transfusion.
Data collection. Demographic and clinical characteristics of
patients as well as detailed procedural characteristics werean employee of Medtronic. All other authors have reported that they have no rela-
tionships relevant to the contents of this paper to disclose.
Manuscript received May 28, 2013; revised manuscript received August 19, 2013,
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1140prospectively collected. For patients undergoing ad hoc PCI
in addition to diagnostic angiography, the various study
endpoints were recorded separately for diagnostic angiog-
raphy and for PCI. The data on performance of aortography
(to determine bypass graft anatomy), arterial access cross-
over, and periprocedural complications were collected. The
patients’ cumulative skin dose was calculated from air kerma
values. The operators’ radiation exposure was measured
using a pocket dosimeter device (BleeperSv, Vertec, Berk-
shire, United Kingdom). Data regarding patient satisfaction
including access site and overall discomfort, earliest time to
ambulation after the procedure, and future access site pref-
erence were collected the day after the procedure.
Statistical analysis. Categorical variables were presented as
percentages and compared using the chi-square or Fisher’s
exact test, as appropriate. Continuous variables were presented
as mean SD and compared using the t test orWilcoxon rank
sum test, as appropriate. Assuming a mean contrast volume of
165 65ml in patients who had previously undergoneCABG
surgery undergoing TF cardiac catheterization (16), a sample
size of 128 patients was needed to have 80% power to detect
20% higher contrast use with TR access (alpha ¼ 0.05).Figure 1. Flowchart of Patient Screening and Enrollment
Flowchart demonstrating patient selection, randomization and treatment. cath ¼ c
TR ¼ transradial.All statistical analyses were performed with JMP version 9.0
(SAS Institute Inc., Cary, North Carolina). Analyses were
performed by intention-to-treat, and a p value of <0.05 was
considered statistically signiﬁcant.
Results
During the study period, 237 patients were screened for
participation. Of these, 109 patients were excluded (Fig. 1),
leaving a total of 128 patients for enrollment and random-
ization (64 to TR access and 64 to TF access). Nearly all
(126 of 128) study patients underwent diagnostic angiog-
raphy, whereas 2 patients only underwent PCI. The mean
patient age was 65.7  8.2 years; all patients were men, and
most presented with stable angina. The baseline character-
istics of the 2 study groups were well balanced (Table 1).
Procedural outcomes for diagnostic coronary angiography.
Angiographic and procedural data for diagnostic coronary
angiography (n ¼ 126) are depicted in Table 2. Compared
with TF access, patients undergoing cardiac catheterization
via TR access had higher contrast use (142  39 ml vs.
171  72 ml, p < 0.01), longer procedure durationatheterization; PCI ¼ percutaneous coronary intervention; TF ¼ transfemoral;
Table 1. Demographic and Baseline Characteristics of the Study Population
Characteristics
Radial Access
(n ¼ 64)
Femoral Access
(n ¼ 64) p Value
Age, yrs 64.7  6.3 66.7  6.3 0.15
Men, % 100.0 100.0 1.00
Body mass index, kg/m2 31.9  5.5 30.0  5.4 0.22
Clinical presentation 0.47
Stable angina 35.9 46.8
Unstable angina 20.3 18.7
NSTEMI 10.9 12.5
Other* 32.8 21.9
Hypertension 92.2 92.2 1.00
Hyperlipidemia 94.0 98.4 0.55
Diabetes 50.0 60.9 0.21
Current smoking 14.1 15.6 0.80
Previous smoking 89.6 90.6 0.77
Heart failure 43.6 56.3 0.21
No. of years since CABG surgery 7.7 9.5 0.16
Previous myocardial infarction 53.3 46.7 0.48
Previous PCI 51.4 48.6 0.72
Previous stroke 9.3 4.7 0.29
Peripheral artery disease 14.1 9.38 0.41
Known CABG anatomy 82.8 90.6 0.19
Values given are mean  SD or %. *Ventricular arrhythmias, cardiomyopathy, study follow-up.
CABG ¼ coronary artery bypass graft; NSTEMI ¼ non–ST-segment elevation myocardial
infarction; PCI ¼ percutaneous coronary intervention.
Table 3. Procedural Outcomes and Resource Use in Percutaneous
Coronary Intervention
Radial Access
(n ¼ 24)
Femoral Access
(n ¼ 30) p Value
Contrast volume, ml 132  80 138  64 0.86
Procedure time, min 41  20 45  27 0.47
Fluoroscopy time, min 11.1  6.8 12.1.0  8.7 0.64
Patient air kerma radiation
exposure, Gy
1.19  0.69 1.56  0.14 0.18
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1141(21.9  6.8 min vs. 34.2  14.7 min, p < 0.01), increased
ﬂuoroscopy time (8.5  4.7 min vs. 12.7  6.6 min,
p < 0.01), and greater mean air kerma radiation exposure in
patients (1.08  0.54 Gy vs. 1.29  0.67 Gy, p ¼ 0.055).
Similarly, compared with TF, TR catheterization was
associated with greater mean operator radiation exposure
(1.3  1.0 mrem vs. 2.6  1.7 mrem, p < 0.01 for the ﬁrst
operator and 0.8  1.1 mrem vs. 1.8  2.1 mrem, p ¼ 0.01
for the second operator). More diagnostic catheters were
used for TR compared with TF catheterization (p ¼ 0.04).Table 2. Procedural Outcomes and Resource Use in Patients Undergoing
Diagnostic Coronary Angiography
Radial Access
(n ¼ 63)
Femoral Access
(n ¼ 63) p Value
Contrast volume, ml 171  72 142  39 <0.01
Procedure time, min 34.2  14.7 21.9  6.8 <0.01
Fluoroscopy time, min 12.7  6.6 8.5  4.7 <0.01
Patient air kerma radiation
exposure, Gy
1.29  0.67 1.08  0.54 0.06
First operator radiation exposure,
mrem
2.6  1.7 1.3  1.0 <0.01
Second operator radiation
exposure, mrem
1.8  2.1 0.8  1.1 0.01
No. of patent grafts 2.2  1.0 2.3  0.9 0.56
No. of diagnostic catheters used 3.3  1.3 2.9  0.7 0.04
Values are mean  SD.The arterial access crossover rates were 17.2% for TR and
0% for TF (p < 0.01). The reasons for failure were radial
artery dissection (n ¼ 1), radial artery perforation (n ¼ 1),
and inability to engage a native coronary artery (n ¼ 1) or
a saphenous vein graft (n ¼ 8). Aortography was performed
in 6.2% of the patients in both groups. An arterial closure
device was used in 54.7% of the patients in the TF group as
follows: Angio-Seal (St. Jude Medical, St. Paul, Minnesota)
in 26 patients (74.3%); Perclose (Abbott Vascular, Santa
Clara, California) in 6 patients (17.1%); and EXOSEAL
(Cordis, Miami Lakes, Florida) in 3 patients (8.6%).
Procedural outcomes of PCI. In the PCI cohort, more
patients underwent ad hoc PCI in the TF group (n ¼ 30)
than those in the TR group (n ¼ 24) (p ¼ 0.28) (Table 3).
In 4 patients who were randomized to TR access, ad hoc
PCI was not performed due to anticipated procedural
complexity; PCI was performed the following day in
3 patients and 2 days later on the fourth patient using TF
access. Stent use and saphenous vein graft interventions were
signiﬁcantly more common in the TF access group. No
signiﬁcant differences were observed in contrast volume,
procedure time, ﬂuoroscopy time, and patient/operator
radiation exposure (Table 3).
Clinical outcomes. All PCI attempts were successful in both
groups, and there were no major periprocedural complica-
tions. One patient in the TF group had transient numbness
of the right upper extremity that lasted <30 min andFirst operator radiation
exposure, mrem
0.81  0.71 1.39  1.76 0.25
Second operator radiation
exposure, mrem
1.33  1.04 0.9  0.72 0.23
No. of lesions treated 1.33  0.63 1.40  0.56 0.68
No. of stents used 0.9  0.7 1.6  1.2 0.02
Average stent length, cm 27  12 42  27 0.02
No. of balloons used 2.0  0.9 2.8  2.5 0.15
Stent deployment 80.0 79.1 0.95
Balloon angioplasty alone 20.0 20.9 0.95
Target vessel undergoing intervention 0.03
Saphenous venous graft 20.8 36.7
Left circumﬂex 29.2 23.2
Right coronary artery 16.7 26.7
Left anterior descending artery 33.3 3.3
Left main 4.1 10.0
Left internal mammary artery graft 4.1 10.0
Values are mean  SD, or %.
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1142spontaneously subsided. Magnetic resonance imaging of the
brain did not demonstrate any acute injury. A total of
4 patients (2 from each group) had minor vascular compli-
cations (3.1% each). In the TR group, 1 patient had radial
artery intimal dissection and another patient had minor
radial artery perforation. Both patients had a patent left
radial artery on discharge. In the TF group, groin hema-
tomas developed in 2 patients with no evidence of aneurysm,
pseudoaneurysm, arteriovenous ﬁstula formation, or signif-
icant decrease in hemoglobin.
All patients completed a questionnaire before hospital
discharge. The preferred access for future cardiac catheteri-
zation was TR in 48%, followed by either access in 26%
and TF in 26%. When analyzed according to randomiza-
tion, patients in the TR group were likely to prefer radial
access compared with patients in the TF group, as depicted
in Figure 2 (p < 0.01).
Discussion
The major ﬁndings of the RADIAL-CABG trial are that
among patients who previously had undergone CABG
surgery and now require diagnostic angiography, compared
with TF access, TR access was associated with: 1) greater
contrast use; 2) longer procedure and ﬂuoroscopy time; 3)
greater patient and operator radiation exposure; 4) higher
crossover rates to TF; and 5) greater patient satisfaction. No
signiﬁcant differences in these parameters were observed
among patients undergoing PCI, although PCI via TF
access appeared to be more complex than PCI via TR access.
The RADIAL-CABG trial is the ﬁrst prospective,
randomized, controlled trial to compare procedural efﬁciency
and outcomes with TR access versus TF access among patientsFigure 2. Patients’ Access Preference for Future Catheterization
Information collected 24 h after their respective procedures. Abbreviations as in Figwho had previously undergone CABG surgery and scheduled
to undergo diagnostic angiography and/or PCI. Diagnostic
angiography via TR access was associated with greater contrast
and catheter use and operator radiation exposure. This is not
surprising because engaging bypass grafts via TR access can be
more challenging than viaTFaccess, especially via the left radial
approach. The greater difﬁculty in engaging a bypass graft was
also reﬂected in the high access crossover rates (17.2%with TR
vs. 0%with TF). Although the ﬁrst operator inmany cases was
a cardiology trainee, an experienced interventional cardiologist
promptly assumed the primary operator role if difﬁculty was
encountered, including all crossover cases. Such a “fellow ﬁrst”
strategy (2 to 3 attempts by a fellow followed by attempts by an
attending)may have contributed to higher failure and crossover
rates because multiple access attempts and excessive catheter
manipulation can lead to radial artery spasm and/or intimal
dissection.Our TR toTF access crossover rate of 17% is higher
than the 3.8% to 5.8% rates reported in retrospective studies on
patients who had previously undergone CABG surgery by
other authors (10–12). Several factors might have contributed
to this difference, such as the “fellow-ﬁrst” strategy, selection
bias in observational studies, and possibly differences in the
patient populations included in various studies. However, in
a large academic center, the overall crossover rate from TR to
TF access was 9.1% during transition from TF to TR as the
preferred vascular access (65%of all procedureswere doneusing
TR access during the study period) (17).
When attempting cardiac catheterization using TR
access, TF crossover may be needed because of inability to
puncture or cannulate the radial artery (10,15,18–22), radial
artery spasm (15,20–22), failure to advance catheters or
guidewires (10,15,18,22), and inability to cannulate/engage
the target vessel (11,15,23). In cases of TR access failure,ure 1.
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1143prompt crossover to TF access may shorten the total
procedure time (24), but there is no universally accepted
threshold for performing the switch; hence, it is heavily
dependent on each operator’s experience and judgment.
Published literature on TR versus TF access often reports no
signiﬁcant difference in procedure times, contrast use, or
radiation exposure between the 2 approaches; however, most
of these studies were not randomized trials, making the
results subject to selection bias. Furthermore, even among
randomized trials that included patients who had previously
undergone CABG surgery, those patients only formed a
small minority of the total study cohort (8–13,15,23,25–31).
The ﬁnding of a prolonged procedure time with TR access
is in agreement with the ﬁndings of Brueck et al. (15)
and Sallam et al. (27), but this was not observed in other
studies (9–12,14). Some of the possible reasons for this
discrepancy could be underrepresentation of CABG patients
in the majority of these studies, selection bias, and the
learning curve of fellows who often assumed the role of
a primary operator.
Consistent with multiple previous studies, ﬂuoroscopy time
was signiﬁcantly longer with TR access (1,4,25,26,28,31),
likely reﬂecting the increased technical difﬁculty of cannu-
lating native coronary arteries and bypass grafts using this
approach. As a result, TR access was associated with
a numerically higher but nonsigniﬁcant trend (p ¼ 0.055)
toward higher air kerma patient radiation exposure, which is
similar to ﬁndings of previous studies (13,25,26,28,29,31).
From an operator perspective, TR access was associated with
signiﬁcantly greater operator radiation exposure during
diagnostic angiography compared with TF access. Although
this may be at least partially explained increased ﬂuoroscopy
time required to engage bypass grafts from a TR approach,
another likely contributing factor is use of the left radial
access, which often requires the operator to “bend over” the
patient and, hence, be more exposed to radiation. Increased
operator radiation exposure with TR access is described in
multiple previous studies (23,26,28) and is a cause for
concern because over time it can lead to signiﬁcant adverse
health consequences.
No difference was observed in procedural efﬁciency and
radiation exposure between TF access and TR access during
PCI; however, this is likely explained by differential case
selection. TF access PCI was of higher complexity compared
with TR access, as suggested by the greater number of stents
and longer total stent length. Four patients in the TR group
did not undergo ad hoc PCI, but instead returned for PCI
via TF access within the ﬁrst 2 days after diagnostic angi-
ography. In contrast, all TF access patients requiring PCI
underwent ad hoc PCI. A major advantage of the TR versus
the TF approach is the lower rate of major vascular access
complications; however, no such difference was observed in
the present study, likely due to small sample size and an
overall low incidence of MACE. Moreover, the exclusion ofpatients with ST-segment elevation myocardial infarction
from the study and higher crossover rate (along with inten-
tion-to-treat analysis) might have contributed to the absence
of the favorable MACE and vascular access complication
outcomes that have been reported in the TR access group in
previous studies. Consistent with previous reports (9,32),
patient satisfaction was greater with TR access.
Our study raises several questions about the relative risks
and beneﬁts associated with TR access versus TF access in
patients who had previously undergone CABG surgery.
Whether the longer procedure duration and greater resource
use and radiation exposure (to patient and operator) with TR
access are sufﬁciently offset by improved patient comfort
and the lower likelihood of vascular access complications
needs to be assessed for each individual patient. This deci-
sion is complicated by that fact that almost 1 in 5 patients
who had previously undergone CABG surgery may require
crossover from a TR to TF approach when undergoing
cardiac catheterization.
Study limitations. First, as expected in a predominantly male
veteran population, only men were included in the study,
which may limit extrapolation to women. Men often have
several comorbidities (33) and challenging coronary
anatomy; however, most patients who had previously
undergone CABG surgery undergoing coronary angiog-
raphy and PCI are men (34). Second, the decision to
perform ad hoc PCI in the 2 study groups was at the
discretion of the operator, and as a result, fewer TR access
patients underwent ad hoc PCI. Third, cardiology trainees
who have less experience in using TR access often served as
ﬁrst operators, which may result in increased contrast and
ﬂuoroscopy use; however, an experienced operator was
overseeing every procedure and promptly assumed the
primary operator role when needed. Fourth, the high
crossover rates from TR to TF access may have attenuated
the differences between the 2 study groups, although
differences were still highly statistically signiﬁcant for most
endpoints.Conclusions
In summary, TR access for diagnostic angiography in
patients who had previously undergone CABG surgery was
associated with lower procedural efﬁciency and higher
contrast and radiation exposure for both the patient and the
operator, but also greater patient satisfaction. This infor-
mation can assist with access site selection in this chal-
lenging group of patients.
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